These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12868510)

  • 1. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.
    Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ
    Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510
    [No Abstract]   [Full Text] [Related]  

  • 2. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 3. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries.
    Soares JC
    Bipolar Disord; 2000 Mar; 2(1):37-41. PubMed ID: 11254018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal effects of valproic acid?
    Garland EJ; Behr R
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 7. [The dangers of valproate in women].
    Isojärvi J
    Duodecim; 1998; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 9. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
    O'Donovan C; Kusumakar V; Graves GR; Bird DC
    J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered ovarian function and cardiovascular risk factors in valproate-treated women.
    Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS
    Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VALPROATE, BIPOLAR DISORDER AND POLYCYSTIC OVARIAN SYNDROME.
    Okanović M; Zivanović O
    Med Pregl; 2016; 69(3-4):121-6. PubMed ID: 27506102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case reports.
    Betts T
    Seizure; 2001 Apr; 10(3):229-34. PubMed ID: 11437624
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 15. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L; Meo R
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.
    Rasgon NL; Altshuler LL; Gudeman D; Burt VK; Tanavoli S; Hendrick V; Korenman S
    J Clin Psychiatry; 2000 Mar; 61(3):173-8. PubMed ID: 10817101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
    Reynolds MF; Sisk EC; Rasgon NL
    Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate.
    Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G
    Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.